Celltrion Receives Positive CHMP Opinion for Three Biosimilars in the European Union
INCHEON, South Korea, December 15, 2024–(BUSINESS WIRE)–Celltrion today announced that the Committee for Medicinal Products for Human Use…
Browsing Tag